Back
Kymera Therapeutics Vs. Dutch Bros Industry Stock Comparison
Buy
75
KYMR
Kymera Therapeutics
Last Price:
48.67
Seasonality Move:
52.76%
Buy
100
BROS
Dutch Bros
Last Price:
47.48
Seasonality Move:
-3.66%
Buy
75
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $50.05. The Score for KYMR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Dutch Bros (BROS)
is a Buy
Is Dutch Bros a Buy, Sell or Hold?
- The current Dutch Bros [BROS] share price is $48.78. The Score for BROS is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- BROS is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $50.05
The current trend is moderately bullish and KYMR is experiencing slight selling pressure.
BROS Stock Price Chart
What is Dutch Bros's stock price today?
-
The Dutch Bros share price today is $48.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BROS is experiencing slight buying pressure.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 57.39 | Buy |
| Chaikin Money Flow: | -137989 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.13 - 49.75) | Buy |
| Bollinger Bands (100): | (38.59 - 49.75) | Buy |
BROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.18 | Buy |
| Relative Strength Index (14 RSI): | 84.91 | Buy |
| Chaikin Money Flow: | 532541 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.1 - 41.22) | Buy |
| Bollinger Bands (100): | (31.18 - 39.96) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.18 | Buy |
| 20-day SMA: | 48.27 | Buy |
| 50-day SMA: | 47.21 | Buy |
| 200-day SMA: | 40.45 | Buy |
| 8-day EMA: | 49.65 | Buy |
| 20-day EMA: | 48.44 | Buy |
| 50-day EMA: | 46.96 | Buy |
| 200-day EMA: | 40.14 | Buy |
BROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.52 | Buy |
| 20-day SMA: | 37.07 | Buy |
| 50-day SMA: | 34.56 | Buy |
| 200-day SMA: | 33.86 | Buy |
| 8-day EMA: | 42.7 | Buy |
| 20-day EMA: | 38.42 | Buy |
| 50-day EMA: | 35.83 | Buy |
| 200-day EMA: | 33.95 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.50 per share.
Dutch Bros Earnings Growth & BROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.09 per share.
Kymera Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dutch Bros Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||